ClinConnect ClinConnect Logo
Search / Trial NCT06614530

Effectiveness of Chilipad in Enhancing Sleep Quality & Wellbeing

Launched by EFFORIA, INC · Sep 24, 2024

Trial Information

Current as of July 06, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how the Chilipad Dock Pro Bed Cooling System and Sleep Tracker can improve sleep quality and overall well-being. The study will last for 35 days, during which participants will use the cooling system while sleeping and provide feedback about their sleep experiences. The goal is to see if adjusting the temperature of their sleeping environment can help them sleep better and feel healthier.

To be eligible for this trial, you need to be a recent customer of Sleep.me, live in the United States, and be between the ages of 76 and 70. However, certain individuals are excluded, such as those with severe insomnia, serious allergies or skin conditions, or those who frequently travel across time zones. Participants will have a simple role: set up the device, sleep, and share their thoughts on how well they slept throughout the study. This trial is not yet recruiting, so keep an eye out for updates if you’re interested!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • in the United States
  • recent purchaser or customer of Sleep.me
  • Exclusion Criteria:
  • Individuals with severe insomnia
  • Individuals with severe allergies or skin conditions
  • Individuals with pacemakers or implanted medical devices
  • Individuals with severe anxiety or stress disorders
  • Pregnant individuals
  • Individuals who travel across timezones frequently and/or sleep in their own bed less than 21 days in a month.
  • Individuals with incontinence issues
  • Individuals with severe mobility issues.

About Efforia, Inc

Efforia, Inc. is a pioneering clinical trial sponsor dedicated to advancing innovative therapies in the healthcare sector. With a strong focus on precision medicine, Efforia leverages cutting-edge research and technology to design and conduct rigorous clinical trials aimed at addressing unmet medical needs. The organization collaborates closely with healthcare professionals, regulatory bodies, and industry partners to ensure the highest standards of safety and efficacy in its trials. Committed to improving patient outcomes, Efforia is at the forefront of transforming healthcare through its strategic approach to drug development and clinical research.

Locations

Patients applied

0 patients applied

Trial Officials

Matthew M Amsden, MBA

Principal Investigator

Efforia, Inc

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported